Optune Video Library
Watch videos to learn more about the science behind Optune. Leading healthcare providers, patients, and caregivers share their experiences with the Optune EF-14 clinical trial.
Select video category:
Dr. Khagi’s Journey with Optune 05:11
Neuro-oncologist, Dr. Khagi, took action to better understand what his patients experience. He shaved his head, wore Optune, and ran a 5K in the spirit of standing in solidarity with his patients. Watch this inspiring video to hear more about Dr. Khagi’s personal experience prescribing and wearing Optune.
Navigating Your Neuro-Oncology Patients 59:23
Learn about neuro-oncology nurse navigation and the importance of the nurse navigator role in helping patients with GBM throughout their treatment journey. This presentation also features a patient case that demonstrates the role of nurse navigators.
Learn About Optune
Learn about TTFields Mechanism of Action 04:47
Watch this short video to learn the science behind Tumor Treating Fields (TTFields).
How Does Optune Work? 02:21
Watch how Tumor Treating Fields (TTFields) can disrupt cancer cells from dividing. This video shows in vitro evidence of Optune’s mechanism of action.
Transducer Arrays Placement 07:56
Detailed step-by-step instructions on how to apply and replace Optune transducer arrays that deliver treatment to the location of the tumor.
Changing Patient’s Lives with Optune—A Storytelling Video Pt 1 03:25
Understand how the critical dialog between healthcare providers and patients can impact a patient’s life with the common goal of maintaining mental, emotional, & physical well-being
Changing Patient’s Lives with Optune—A Storytelling Video Pt 2 04:32
Part 2 of this story follows an HCP’s and patient’s experiences with Optune for treating glioblastoma
Lifetime TV’s The Balancing Act® segment on GBM 09:09
Glioblastoma multiforme or GBM is a rare brain tumor that can be difficult to treat and the prognosis is poor
Support services 03:00
See Optune patients and caregivers share how nCompass® helps with 24/7 support.
Device Support Specialists (DSS) 02:17
Discover how others still do the things they love while on Optune.
A caregiver’s guide 03:09
Hear caregivers’ insights about caring for Optune patients and themselves.
Indications for Use
Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).
Optune with temozolomide is indicated for the treatment of adult patients with newly diagnosed, supratentorial glioblastoma following maximal debulking surgery, and completion of radiation therapy together with concomitant standard of care chemotherapy.
Important Safety Information
Do not use Optune in patients with an active implanted medical device, a skull defect (such as, missing bone with no replacement), or bullet fragments. Use of Optune together with implanted electronic devices has not been tested and may theoretically lead to malfunctioning of the implanted device. Use of Optune together with skull defects or bullet fragments has not been tested and may possibly lead to tissue damage or render Optune ineffective.
Do not use Optune in patients that are known to be sensitive to conductive hydrogels. In this case, skin contact with the gel used with Optune may commonly cause increased redness and itching, and rarely may even lead to severe allergic reactions such as shock and respiratory failure.
Warnings and Precautions
The most common (≥10%) adverse events involving Optune in combination with temozolomide were thrombocytopenia, nausea, constipation, vomiting, fatigue, medical device site reaction, headache, convulsions, and depression.
If the patient has an underlying serious skin condition on the scalp (e.g. ulcers, open wound, broken skin) evaluate whether this may prevent or temporarily interfere with Optune treatment.
Use of Optune in patients with an inactive implanted medical device in the brain has not been studied for safety and effectiveness, and use of Optune in these patients could lead to tissue damage or lower the chance of Optune being effective.
Do not prescribe Optune for patients that are pregnant, you think might be pregnant or are trying to get pregnant, as the safety and effectiveness of Optune in these populations have not been established.
Optune can only be prescribed by a healthcare provider that has completed the required certification training provided by Novocure (the device manufacturer).
Please click here to see the Optune Instructions for Use (IFU) for complete information regarding the device’s indications, contraindications, warnings and precautions.